Literature DB >> 9225696

Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation.

R Crook1, R Ellis, M Shanks, L J Thal, J Perez-Tur, M Baker, M Hutton, T Haltia, J Hardy, D Galasko.   

Abstract

We describe a new mutation causing Alzheimer's disease (AD) in presenilin-1 (N135D) that is at the homologous site to the presenilin 2 mutation (N141I) in Volga German kindreds. The phenotype of PS1 N135D is an early-onset (34-38 years) disease. The mutation forms part of, and extends, the alpha-helical array of mutations in transmembrane 2 of the presenilins and leads to the suggestion that disruption of this helical face is the molecular insult that leads to disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225696     DOI: 10.1002/ana.410420121

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

Review 2.  Assembly, maturation, and trafficking of the gamma-secretase complex in Alzheimer's disease.

Authors:  Daniel R Dries; Gang Yu
Journal:  Curr Alzheimer Res       Date:  2008-04       Impact factor: 3.498

3.  Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease.

Authors:  Marissa Natelson Love; David G Clark; J Nicholas Cochran; Kyle A Den Beste; David S Geldmacher; Tammie L Benzinger; Brian A Gordon; John C Morris; Randall J Bateman; Erik D Roberson
Journal:  Neurobiol Aging       Date:  2016-10-03       Impact factor: 4.673

4.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

5.  Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS.

Authors:  N D Schmitt; J N Agar
Journal:  J Mass Spectrom       Date:  2017-07       Impact factor: 1.982

Review 6.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

Review 7.  Interactions of pathological proteins in neurodegenerative diseases.

Authors:  Tara L Spires-Jones; Johannes Attems; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2017-04-11       Impact factor: 17.088

8.  Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes.

Authors:  Jorge J Llibre-Guerra; Yan Li; Ricardo F Allegri; Patricio Chrem Mendez; Ezequiel I Surace; Juan J Llibre-Rodriguez; Ana Luisa Sosa; Carmen Aláez-Verson; Erika-Mariana Longoria; Alberto Tellez; Karol Carrillo-Sánchez; Luis Leonardo Flores-Lagunes; Victor Sánchez; Leonel Tadao Takada; Ricardo Nitrini; Norberto Anizio Ferreira-Frota; Joyce Benevides-Lima; Francisco Lopera; Laura Ramírez; Ivonne Jiménez-Velázquez; Christian Schenk; Daisy Acosta; María Isabel Behrens; Michelle Doering; Ellen Ziegemeier; John C Morris; Eric McDade; Randall J Bateman
Journal:  Alzheimers Dement       Date:  2020-11-23       Impact factor: 21.566

Review 9.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.